A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV

Alexander C. Tsai, Sheri D. Weiser, Maya L. Petersen, Kathleen Ragland, Margot B. Kushel, David Bangsberg

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Context: Depression strongly predicts nonadherence to human immunodeficiency virus (HIV) antiretroviral therapy, and adherence is essential to maintaining viral suppression. This suggests that pharmacologic treatment of depression may improve virologic outcomes. However, previous longitudinal observational analyses have inadequately adjusted for time-varying confounding by depression severity, which could yield biased estimates of treatment effect. Application of marginal structural modeling to longitudinal observation data can, under certain assumptions, approximate the findings of a randomized controlled trial. Objective: To determine whether antidepressant medication treatment increases the probability of HIV viral suppression. Design: Community-based prospective cohort study with assessments conducted every 3 months. Setting: Community-based research field site in San Francisco, California. Participants: One hundred fifty-eight homeless and marginally housed persons with HIV who met baseline immunologic (CD4+ T-lymphocyte count, <350/μL) and psychiatric (Beck Depression Inventory II score, >13) inclusion criteria, observed from April 2002 through August 2007. Main Outcome Measures: Probability of achieving viral suppression to less than 50 copies/mL. Secondary outcomes of interest were probability of being on an antiretroviral therapy regimen, 7-day self-reported percentage adherence to antiretroviral therapy, and probability of reporting complete (100%) adherence. Results: Marginal structural models estimated a 2.03 greater odds of achieving viral suppression (95% confidence interval [CI], 1.15-3.58; P=.02) resulting from antidepressant medication treatment. In addition, antidepressant medication use increased the probability of antiretroviral uptake (weighted odds ratio, 3.87; 95% CI, 1.98-7.58; P < .001). Self-reported adherence to antiretroviral therapy increased by 25 percentage points (95% CI, 14-36;P < .001), and the odds of reporting complete adherence nearly doubled (weighted odds ratio, 1.94; 95% CI, 1.20-3.13; P=.006). Conclusions: Antidepressant medication treatment increases viral suppression among persons with HIV. This effect is likely attributable to improved adherence to a continuum of HIV care, including increased uptake and adherence to antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)1282-1290
Number of pages9
JournalArchives of General Psychiatry
Volume67
Issue number12
DOIs
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Structural Models
Antidepressive Agents
HIV
Confidence Intervals
Odds Ratio
Therapeutics
San Francisco
CD4 Lymphocyte Count
Cohort Studies
Randomized Controlled Trials
Observation
Outcome Assessment (Health Care)
Prospective Studies
T-Lymphocytes
Research

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. / Tsai, Alexander C.; Weiser, Sheri D.; Petersen, Maya L.; Ragland, Kathleen; Kushel, Margot B.; Bangsberg, David.

In: Archives of General Psychiatry, Vol. 67, No. 12, 12.2010, p. 1282-1290.

Research output: Contribution to journalArticle

Tsai, Alexander C. ; Weiser, Sheri D. ; Petersen, Maya L. ; Ragland, Kathleen ; Kushel, Margot B. ; Bangsberg, David. / A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. In: Archives of General Psychiatry. 2010 ; Vol. 67, No. 12. pp. 1282-1290.
@article{e615a48bb6d14dc19a8caf171657e857,
title = "A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV",
abstract = "Context: Depression strongly predicts nonadherence to human immunodeficiency virus (HIV) antiretroviral therapy, and adherence is essential to maintaining viral suppression. This suggests that pharmacologic treatment of depression may improve virologic outcomes. However, previous longitudinal observational analyses have inadequately adjusted for time-varying confounding by depression severity, which could yield biased estimates of treatment effect. Application of marginal structural modeling to longitudinal observation data can, under certain assumptions, approximate the findings of a randomized controlled trial. Objective: To determine whether antidepressant medication treatment increases the probability of HIV viral suppression. Design: Community-based prospective cohort study with assessments conducted every 3 months. Setting: Community-based research field site in San Francisco, California. Participants: One hundred fifty-eight homeless and marginally housed persons with HIV who met baseline immunologic (CD4+ T-lymphocyte count, <350/μL) and psychiatric (Beck Depression Inventory II score, >13) inclusion criteria, observed from April 2002 through August 2007. Main Outcome Measures: Probability of achieving viral suppression to less than 50 copies/mL. Secondary outcomes of interest were probability of being on an antiretroviral therapy regimen, 7-day self-reported percentage adherence to antiretroviral therapy, and probability of reporting complete (100{\%}) adherence. Results: Marginal structural models estimated a 2.03 greater odds of achieving viral suppression (95{\%} confidence interval [CI], 1.15-3.58; P=.02) resulting from antidepressant medication treatment. In addition, antidepressant medication use increased the probability of antiretroviral uptake (weighted odds ratio, 3.87; 95{\%} CI, 1.98-7.58; P < .001). Self-reported adherence to antiretroviral therapy increased by 25 percentage points (95{\%} CI, 14-36;P < .001), and the odds of reporting complete adherence nearly doubled (weighted odds ratio, 1.94; 95{\%} CI, 1.20-3.13; P=.006). Conclusions: Antidepressant medication treatment increases viral suppression among persons with HIV. This effect is likely attributable to improved adherence to a continuum of HIV care, including increased uptake and adherence to antiretroviral therapy.",
author = "Tsai, {Alexander C.} and Weiser, {Sheri D.} and Petersen, {Maya L.} and Kathleen Ragland and Kushel, {Margot B.} and David Bangsberg",
year = "2010",
month = "12",
doi = "10.1001/archgenpsychiatry.2010.160",
language = "English (US)",
volume = "67",
pages = "1282--1290",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV

AU - Tsai, Alexander C.

AU - Weiser, Sheri D.

AU - Petersen, Maya L.

AU - Ragland, Kathleen

AU - Kushel, Margot B.

AU - Bangsberg, David

PY - 2010/12

Y1 - 2010/12

N2 - Context: Depression strongly predicts nonadherence to human immunodeficiency virus (HIV) antiretroviral therapy, and adherence is essential to maintaining viral suppression. This suggests that pharmacologic treatment of depression may improve virologic outcomes. However, previous longitudinal observational analyses have inadequately adjusted for time-varying confounding by depression severity, which could yield biased estimates of treatment effect. Application of marginal structural modeling to longitudinal observation data can, under certain assumptions, approximate the findings of a randomized controlled trial. Objective: To determine whether antidepressant medication treatment increases the probability of HIV viral suppression. Design: Community-based prospective cohort study with assessments conducted every 3 months. Setting: Community-based research field site in San Francisco, California. Participants: One hundred fifty-eight homeless and marginally housed persons with HIV who met baseline immunologic (CD4+ T-lymphocyte count, <350/μL) and psychiatric (Beck Depression Inventory II score, >13) inclusion criteria, observed from April 2002 through August 2007. Main Outcome Measures: Probability of achieving viral suppression to less than 50 copies/mL. Secondary outcomes of interest were probability of being on an antiretroviral therapy regimen, 7-day self-reported percentage adherence to antiretroviral therapy, and probability of reporting complete (100%) adherence. Results: Marginal structural models estimated a 2.03 greater odds of achieving viral suppression (95% confidence interval [CI], 1.15-3.58; P=.02) resulting from antidepressant medication treatment. In addition, antidepressant medication use increased the probability of antiretroviral uptake (weighted odds ratio, 3.87; 95% CI, 1.98-7.58; P < .001). Self-reported adherence to antiretroviral therapy increased by 25 percentage points (95% CI, 14-36;P < .001), and the odds of reporting complete adherence nearly doubled (weighted odds ratio, 1.94; 95% CI, 1.20-3.13; P=.006). Conclusions: Antidepressant medication treatment increases viral suppression among persons with HIV. This effect is likely attributable to improved adherence to a continuum of HIV care, including increased uptake and adherence to antiretroviral therapy.

AB - Context: Depression strongly predicts nonadherence to human immunodeficiency virus (HIV) antiretroviral therapy, and adherence is essential to maintaining viral suppression. This suggests that pharmacologic treatment of depression may improve virologic outcomes. However, previous longitudinal observational analyses have inadequately adjusted for time-varying confounding by depression severity, which could yield biased estimates of treatment effect. Application of marginal structural modeling to longitudinal observation data can, under certain assumptions, approximate the findings of a randomized controlled trial. Objective: To determine whether antidepressant medication treatment increases the probability of HIV viral suppression. Design: Community-based prospective cohort study with assessments conducted every 3 months. Setting: Community-based research field site in San Francisco, California. Participants: One hundred fifty-eight homeless and marginally housed persons with HIV who met baseline immunologic (CD4+ T-lymphocyte count, <350/μL) and psychiatric (Beck Depression Inventory II score, >13) inclusion criteria, observed from April 2002 through August 2007. Main Outcome Measures: Probability of achieving viral suppression to less than 50 copies/mL. Secondary outcomes of interest were probability of being on an antiretroviral therapy regimen, 7-day self-reported percentage adherence to antiretroviral therapy, and probability of reporting complete (100%) adherence. Results: Marginal structural models estimated a 2.03 greater odds of achieving viral suppression (95% confidence interval [CI], 1.15-3.58; P=.02) resulting from antidepressant medication treatment. In addition, antidepressant medication use increased the probability of antiretroviral uptake (weighted odds ratio, 3.87; 95% CI, 1.98-7.58; P < .001). Self-reported adherence to antiretroviral therapy increased by 25 percentage points (95% CI, 14-36;P < .001), and the odds of reporting complete adherence nearly doubled (weighted odds ratio, 1.94; 95% CI, 1.20-3.13; P=.006). Conclusions: Antidepressant medication treatment increases viral suppression among persons with HIV. This effect is likely attributable to improved adherence to a continuum of HIV care, including increased uptake and adherence to antiretroviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=78649924955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649924955&partnerID=8YFLogxK

U2 - 10.1001/archgenpsychiatry.2010.160

DO - 10.1001/archgenpsychiatry.2010.160

M3 - Article

VL - 67

SP - 1282

EP - 1290

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 12

ER -